Lindbrook Capital’s Lifestance Health LFST Stock Holding History

Lindbrook Capital’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$4.04K	Buy	607 +136	+29%	+$1.03K	﹤0.01%	2046
2024 Q4	$3.47K	Hold	471	–	–	﹤0.01%	2126
2024 Q3	$3.3K	Sell	471 -188	-29%	-$1.13K	﹤0.01%	2178
2024 Q2	$3.24K	Hold	659	–	–	﹤0.01%	2187
2024 Q1	$4.07K	Hold	659	–	–	﹤0.01%	1987
2023 Q4	$5.16K	Hold	659	–	–	﹤0.01%	1867
2023 Q3	$4.53K	Hold	659	–	–	﹤0.01%	1812
2023 Q2	$6.02K	Hold	659	–	–	﹤0.01%	1710
2023 Q1	$4.9K	Sell	659 -33	-5%	-$183	﹤0.01%	1859
2022 Q4	$3.42K	Buy	692 +513	+287%	+$3.17K	﹤0.01%	1992
2022 Q3	$1K	Buy	+179	New	+$1.25K	﹤0.01%	2388

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lindbrook Capital's LFST Position: Q1 2025 in Review

Lindbrook Capital increased its Lifestance Health (LFST) stake by 29% in Q1 2025, buying an estimated $1.03K and bringing the position to 607 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #2046.

Lindbrook Capital first reported a position in LFST in Q3 2022 and has held it in 11 quarters since. The position peaked at $6.02K in Q2 2023. 181 funds tracked by Wall St. Rank hold LFST as of Q1 2025.

Lindbrook Capital held 607 shares of Lifestance Health worth $4.04K as of Q1 2025.
Lindbrook Capital bought 136 Lifestance Health shares in Q1 2025, an estimated $1.03K.
Lifestance Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2046 holding.
Lindbrook Capital first reported a position in Lifestance Health in Q3 2022 and has held it in 11 quarters since.
Lindbrook Capital's Lifestance Health position peaked at $6.02K in Q2 2023.
181 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.